基本信息
浏览量:221
职业迁徙
个人简介
Between 1988 and 1995, he was the recipient of three fellowships in Medical Genetics and Gynecologic Oncology. In 1995, Dr. Monk was appointed Director of Gynecologic Oncology at Texas Tech University Health Services Center and, from 1998 until 2010, was Associate Professor with Tenure of the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology at the Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center and Director of Research in the Department of Obstetrics and Gynecology. Dr. Monk was then appointed Director and Professor in the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, AZ. In 2016, he became a member of Arizona Oncology and part of the US Oncology Network and continues to practice in Phoenix. Most recently, he has been appointed the US Oncology Medical Director of Gynecologic Oncology Research. Dr. Monk is also a Professor on the Clinical Scholar Track at the University of Arizona College of Medicine – Phoenix and works at Arizona Oncology (US Oncology Network). He has been named one of Arizona’s “Top Doctors” by PHOENIX magazine 5 years in a row beginning in 2012.
Dr. Monk’s research interests include the prevention and treatment of gynecologic cancers. He was the first to report the activity of anti-vascular growth factor (VEGF) therapy in ovarian cancer and his papers in the New England Journal of Medicine led to the global approval of anti-VEGF therapy and PARP inhibitors in recurrent ovarian and cervical cancers in 2014. He was also the lead author on the pivotal trial of trabectedin in recurrent ovarian cancer as well as many other studies that have met their primary endpoints. Dr. Monk was also awarded the highly prestigious Ernst Wertheim Award for his research in cervical cancer and is on the Board of Directors for the GOG Foundation, Inc. and is the Cervical Cancer Chair for for the Gynecologic Cancer Intergroup (GCIG). He is past President of the Western Association of Gynecologic Oncologists (WAGO) and current co-director for the GOG Research Consortium (GOG-Partners).
Dr. Monk’s research interests include the prevention and treatment of gynecologic cancers. He was the first to report the activity of anti-vascular growth factor (VEGF) therapy in ovarian cancer and his papers in the New England Journal of Medicine led to the global approval of anti-VEGF therapy and PARP inhibitors in recurrent ovarian and cervical cancers in 2014. He was also the lead author on the pivotal trial of trabectedin in recurrent ovarian cancer as well as many other studies that have met their primary endpoints. Dr. Monk was also awarded the highly prestigious Ernst Wertheim Award for his research in cervical cancer and is on the Board of Directors for the GOG Foundation, Inc. and is the Cervical Cancer Chair for for the Gynecologic Cancer Intergroup (GCIG). He is past President of the Western Association of Gynecologic Oncologists (WAGO) and current co-director for the GOG Research Consortium (GOG-Partners).
研究兴趣
论文共 985 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Oral Sessions (2024)
Late Breaking Abstracts (2024)
Domenica Lorusso,Rebecca S Kristeleit, David M O’Malley,Myong Cheol Lim, Roshan Agarwal,Thomas J Herzog,Michelle K Wilson,Ana Oaknin,Robert L Coleman,Amit Oza, Olga Mikheeva,Larry J Copeland,
Poster and E-Posters (2024)
Giorgio Bogani,Bradley J Monk, Maria-Pilar Barretina-Ginesta,Francesco Raspagliesi,Nicoletta Colombo,Brian Slomovitz,Mansoor Raza Mirza
Poster and E-Posters (2024)
Christof Vulsteke, Setsuko K Chambers, Maria Jesús Rubio Pérez,John K Chan, Nicoline Raaschou-Jensen, Ying Zhuo,Domenica Lorusso,Thomas J Herzog,Thibault De La Motte Rouge, Jessica A Thomes Pepin,Elena Ioana Braicu,Lee-May Chen,
Late Breaking Abstracts (2024)
Journal of clinical oncology : official journal of the American Society of Clinical Oncologypp.JCO2400077-JCO2400077, (2024)
The Lancet Oncologyno. 3 (2024): e96
JAMA oncologyno. 2 (2024): 185-192
Daniel L. Hertz, Markus Joerger, Yung-Jue Bang,Ron H. Mathijssen, Caicun Zhou,Li Zhang, David Gandara,Michael Stahl,Bradley J. Monk, Ulrich Jaehde,Jan H. Beumer
European Journal of Cancer (2024): 114024-114024
Gynecologic Oncology (2024): 54-59
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn